Tiago Girao
CIK 1618670 · Chief Financial Officer · last filed 2026-04-24
Tiago Girao is a Chief Financial Officer who has filed 20 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing shows the insider sold $763.0K of IMVT on Apr 24, 2026. Across all open-market trades the lifetime net is −$729.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.32M
3
20
-$729.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMVT | Chief Financial Officer | 247,596 | $33.62 | $8.32M | -$763.0K | 3 | 2026-04-24 |
| Landos Biopharma, Inc. (LABP) Delisted | Director | — | $22.93 | — | $0 | 5 | 2024-05-23 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | VP & Chief Financial Officer | 14,084 | — | — | $33.1K | 11 | 2017-11-29 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-24 | IMVT | Sell (S) | −25,760 | -$763.0K | EDGAR |
| 2026-04-09 | IMVT | Grant (A) | +64,968 | $0 | EDGAR |
| 2025-05-05 | IMVT | Grant (A) | +208,388 | $0 | EDGAR |
| 2024-05-23 | Landos Biopharma, Inc. (LABP) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-05-24 | Landos Biopharma, Inc. (LABP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Landos Biopharma, Inc. (LABP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-18 | Landos Biopharma, Inc. (LABP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-12 | Landos Biopharma, Inc. (LABP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-27 | — | Exer (X) | — | $0 | |
| 2017-11-29 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Exer (X) | — | $0 | EDGAR |